New drug cocktail aims to keep aggressive lung cancer at bay
NCT ID NCT07376499
Summary
This study is testing whether a combination of four drugs can help control extensive small cell lung cancer after initial treatment. The trial will involve about 31 adults who have not received prior treatment for this advanced cancer stage. Researchers want to see if this maintenance therapy can delay cancer progression and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.